Vallon Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VLON and buy or sell other stocks, ETFs, and their options commission-free!About VLON
GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis.
CEOW. Marc Hertz, PhD
CEOW. Marc Hertz, PhD
Employees4
Employees4
HeadquartersLa Jolla, California
HeadquartersLa Jolla, California
Founded2009
Founded2009
Employees4
Employees4
VLON Key Statistics
Market cap2.62M
Market cap2.62M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume2.55M
Average volume2.55M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$15.64
52 Week high$15.64
52 Week low$0.334
52 Week low$0.334
Stock Snapshot
The current Vallon Pharmaceuticals(VLON) stock price is $0.80, with a market capitalization of 2.62M. The stock trades at a price-to-earnings (P/E) ratio of -0.02.
Vallon Pharmaceuticals(VLON) stock opened on 2025-12-22 at —. The price climbed to — and dipped to —.
Vallon Pharmaceuticals(VLON) shares are trading with a volume of 0, against a daily average of 2.55M.
During the past year, Vallon Pharmaceuticals(VLON) stock moved between $0.33 at its lowest and $15.64 at its peak.
During the past year, Vallon Pharmaceuticals(VLON) stock moved between $0.33 at its lowest and $15.64 at its peak.
People also own
Based on the portfolios of people who own VLON. This list is generated using Robinhood data, and it’s not a recommendation.